Aveo Pharmaceuticals, Inc. Receives $5,499,600 New Financing

  • Feed Type
  • Date
    12/31/2007
  • Company Name
    Aveo Pharmaceuticals, Inc.
  • Mailing Address
    75 Sidney Street Cambridge, MA 02139
  • Company Description
    AVEO is a biopharmaceutical company focused on the discovery and development of novel cancer therapeutics. AVEO is developing a pipeline of targeted therapies which address major unmet medical needs in the field of oncology. The Company utilizes its proprietary in vivo cancer models for the identification and validation of novel drug targets and to guide the development of its products.
  • Website
    http://www.aveopharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,499,600
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Bessemer Venture Partners
  • Venture Investor
    Biogen Idec Inc.
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Highland Capital Partners
  • Venture Investor
    MPM Capital
  • Venture Investor
    Merck Capital Ventures
  • Venture Investor
    Oxford Bioscience Partners
  • Venture Investor
    Prospect Venture Partners
  • Venture Investor
    Venrock